학술논문

Biomarker analysis from Phase 1/2 study of tusamitamab ravtansine (SAR408701) in patients with advanced non-small cell lung cancer (NSCLC)
Document Type
Journal
Source
CANCER RESEARCH; APR 15 2023, 83 8, 3p. Supplement: S
Subject
Language
English
ISSN
15387445